Dr Deepa Narayanan

Dr Deepa Narayanan is a Consultant in Chemical Pathology and Metabolic Medicine based in the United Kingdom. She works at Hull University Teaching Hospitals NHS Trust and also practises privately at Optima Clinics and Spire Hull and East Riding Hospital. Her clinical work focuses on the diagnosis and management of metabolic and biochemical disorders. Her areas of expertise include cholesterol management, lipid disorders such as familial hypercholesterolaemia, cardiovascular risk assessment, and the management of cholesterol levels following cardiovascular events. She also manages metabolic bone conditions, including osteoporosis, osteopenia, vitamin D deficiency, osteomalacia, and Paget’s disease, and provides clinical interpretation of biochemical investigations. Dr Narayanan is the Clinical Lead for lipid and familial hypercholesterolaemia services at Hull University Teaching Hospitals NHS Trust. She has been involved in the development of specialist services, including the implementation of genetic testing pathways for inherited lipid disorders in the Yorkshire and Humber region. In addition to her clinical practice, she is involved in postgraduate medical education and training, acting as a clinical supervisor and tutor. Her work also includes research in lipid disorders, cardiovascular outcomes, and metabolic bone disease, and she has participated as a principal investigator in multicentre clinical trials. Dr Narayanan completed her medical degree in 2002 and obtained Membership of the Royal College of Physicians in 2006. She was elected Fellow of the Royal College of Pathologists in 2014. Her private practice includes specialist assessment and management of cholesterol disorders and metabolic conditions, delivered through structured consultations and evidence-based treatment pathways. 

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2001–2007
   MD · Medicine and Surgery

   Universitat de València (GB)

2. 2007–2011
   Residency · Chemical Pathology

   Universidad de Navarra (GB)

1. 2011-09–2012-08
   Junior consultant

   Universitat de València Teaching Hospital — Chemical Pathology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 3 · i10: 2

Selected publications

1. Validation of clinical scoring in Chemical Pathology

   Dr Deepa Narayanan, et al. · European Journal of Medicine, 2026

   DOI: 10.1560/euroclin.2026.0 · cited by 197

2. Long-term follow-up of Chemical Pathology across GB

   Dr Deepa Narayanan, et al. · European Journal of Medicine, 2025

   DOI: 10.8556/euroclin.2025.1 · cited by 167

• Patient education Patient guide to Chemical Pathology 2026-03-07 · 10 min read
• Awareness When should you see a chemical pathology? 2026-01-04 · 8 min read